Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Clin Exp Immunol ; 183(3): 431-40, 2016 Mar.
Article in English | MEDLINE | ID: mdl-26445891

ABSTRACT

Matrix metalloproteinases (MMPs) are a family of extracellular proteases that play roles in regulating the immune response in inflammatory processes. Previous studies indicated that different MMPs were involved in the host defence and tissue damage in response to different pathogens. However, the contributions of MMPs during Cryptococcus infection have not been addressed clearly. Here, we examined the expression and activity of MMPs during Cryptococcus infection. Among MMP family members, we found significant increases of MMP-3 and MMP-12 mRNA levels and MMP12 zymographic activities in response to C. neoformans but not C. gattii infection. The expression of MMP12 was induced in RAW cells after C. neoformans treatment and in alveolar macrophages purified from C. neoformans-infected mice. Interestingly, administration of MMP inhibitor GM6001 into C. neoformans-infected mice resulted in a significantly increased pulmonary fungal burden with attenuated inflammatory cell infiltration. Corresponding to this finding, the expression of the macrophage- and neutrophil-attracting chemokines CCL2 and CXCL1 was inhibited in the GM6001-treated group and MMP12 levels were found to be correlated strongly with CCL2 mRNA expression. Thus, our data suggest that the induction of MMPs by C. neoformans infection potentiates inflammatory cell infiltration by modulating pulmonary chemokines, thereby promoting effective host immunity to pulmonary Cryptococcus infection.


Subject(s)
Chemokines/metabolism , Cryptococcosis/enzymology , Cryptococcosis/immunology , Matrix Metalloproteinases/metabolism , Pneumonia/immunology , Animals , Chemokine CCL2/genetics , Chemokine CCL2/immunology , Chemokine CXCL1/genetics , Chemokine CXCL1/immunology , Chemokines/genetics , Chemokines/immunology , Cryptococcosis/microbiology , Cryptococcus gattii/immunology , Cryptococcus neoformans/immunology , Cryptococcus neoformans/pathogenicity , Dipeptides/administration & dosage , Disease Models, Animal , Gene Expression Regulation , Matrix Metalloproteinase 12/genetics , Matrix Metalloproteinase 12/immunology , Matrix Metalloproteinase 3/genetics , Matrix Metalloproteinase 3/immunology , Matrix Metalloproteinase Inhibitors/administration & dosage , Matrix Metalloproteinases/genetics , Mice , Mice, Inbred C57BL , Pneumonia/enzymology , Pneumonia/microbiology , RAW 264.7 Cells
2.
Clin Exp Immunol ; 165(1): 19-28, 2011 Jul.
Article in English | MEDLINE | ID: mdl-21501148

ABSTRACT

Early-life respiratory viral infections are linked to subsequent development of allergic asthma in children. We assessed the underlying immunological mechanisms in a novel model of the induction phase of childhood asthma. BALB/c mice were infected neonatally with pneumonia virus of mice, then sensitized intranasally with ovalbumin following recovery. Animals were challenged with low levels of aerosolized ovalbumin for 4 weeks to induce changes of chronic asthma, then received a single moderate-level challenge to elicit mild acute allergic inflammation. To inhibit the initial induction of a T helper type 2 (Th2) response, we administered neutralizing antibodies against interleukin (IL)-4 or IL-25, then assessed development of airway inflammation and remodelling. Anti-IL-4 administered during chronic challenge prevented development of chronic and acute allergic inflammation, as well as goblet cell hyperplasia/metaplasia, but features of remodelling such as subepithelial fibrosis and epithelial hypertrophy were unaffected. In contrast, anti-IL-25 had limited effects on the airway inflammatory response but prevented key changes of remodelling, although it had no effect on goblet cells. Both antibodies suppressed development of a Th2 response, while anti-IL-25 also promoted a Th17 response. In further experiments, anti-IL-25 was administered in early life alone, and again had limited effects on airway inflammation, but prevented development of airway wall remodelling. We conclude that in this murine model of childhood asthma, administration of anti-IL-4 or anti-IL-25 prevents development of some key features of asthma, suggesting that suppression of development of a Th2 response during the neonatal period or later in childhood could be effective for primary prevention.


Subject(s)
Asthma/immunology , Goblet Cells/metabolism , Murine pneumonia virus/immunology , Pneumovirus Infections/immunology , Th2 Cells/metabolism , Airway Remodeling/drug effects , Allergens/immunology , Animals , Animals, Newborn , Antibodies, Blocking/administration & dosage , Asthma/physiopathology , Asthma/prevention & control , Cells, Cultured , Child , Disease Models, Animal , Disease Progression , Goblet Cells/drug effects , Goblet Cells/immunology , Goblet Cells/pathology , Humans , Hyperplasia/prevention & control , Interleukin-4/immunology , Interleukins/immunology , Mice , Mice, Inbred BALB C , Murine pneumonia virus/pathogenicity , Ovalbumin/immunology , Pneumonia/prevention & control , Pneumovirus Infections/physiopathology , Pneumovirus Infections/prevention & control , Th2 Cells/drug effects , Th2 Cells/immunology , Th2 Cells/pathology
3.
Trop Med Int Health ; 5(10): 737-43, 2000 Oct.
Article in English | MEDLINE | ID: mdl-11044269

ABSTRACT

Pyrimethamine-sulfadoxine (PS) is used as a second-line treatment for P. falciparum malaria patients who fail to respond to chloroquine. Resistance to these drugs has been shown to encode with point mutations in dihydrofolate reductase (DHFR) and dihydropteroate synthetase (DHPS) genes. Our aim was to assess the comparative rate of point mutation occurring in DHFR and DHPS genes among P. falciparum isolates from India and Thailand where the use of PS is at a different rate. We used the mutation-specific polymerase chain reaction (PCR) technique and mutation-specific restriction digestion to determine the prevalence of DHFR and DHPS gene mutations at codons 16, 51, 59, 108, 164 and at 436, 437, 581 and 613, respectively. In the 89 clinical isolates from India, in the case of the DHFR gene, we found 71 of S108N, 10 of N51I, 28 of C59R and four of I164L types. Among the 50 isolates from Thailand the rate of point mutations in the DHFR gene was higher at four codon positions. We found 47 of S108N, 18 of N51I, 23 of C59R and 12 of I164L types. None of the isolates from either country possessed the paired mutations S108T and A16V. Mutations of the DHPS gene were less frequent among the Indian isolates: 4.5% showed DHPS gene mutation, two of S436F, A437G, A613T and two of S436F, A613T; whereas 66% (33/50) of the Thai isolates had mutated at codons 436, 437, 581 and 613 which include 13 of S436F, 15 of A437G, 19 of A581G and 25 of A613S/T, ranging from single to quadruple mutant types. Among the Indian isolates, DHFR point mutations were very frequent and 85/89 had a wild type DHPS genetic profile. The pattern of mutations in the samples from Thailand was different, as most were associated with point mutations in DHFR and DHPS genes.


Subject(s)
Dihydropteroate Synthase/genetics , Malaria, Falciparum/epidemiology , Plasmodium falciparum/enzymology , Point Mutation , Tetrahydrofolate Dehydrogenase/genetics , Adolescent , Adult , Aged , Animals , Antimalarials/pharmacology , Child , Child, Preschool , Chloroquine/pharmacology , DNA, Protozoan/blood , Drug Resistance/genetics , Female , Humans , India/epidemiology , Infant , Infant, Newborn , Malaria, Falciparum/parasitology , Male , Middle Aged , Plasmodium falciparum/drug effects , Plasmodium falciparum/genetics , Polymerase Chain Reaction , Prevalence , Thailand/epidemiology
4.
Am J Trop Med Hyg ; 61(5): 780-3, 1999 Nov.
Article in English | MEDLINE | ID: mdl-10586912

ABSTRACT

Resistance to quinoline-containing compound has been associated with the Plasmodium falciparum multidrug resistance 1 (pfmdr1) gene. We analyzed wild P. falciparum isolates with high levels of chloroquine and mefloquine resistance for their macrorestriction maps of chromosome 5 and sequence of pfmdr1. Two types of chromosome 5 amplification were found. Eleven of 62 resistant isolates displayed Bgl 1 fragments larger than 100 kb. Twenty-nine isolates possessed multiple copies of the fragments. We failed to detect any amplification of this region on chromosome 5 in 22 mefloquine-resistant isolates, suggesting that other mechanisms can mediate the mefloquine-resistant phenotype. There was no direct association between pfmdr1 mutations and chloroquine sensitivity. Resistant lines could have Asn-86 and Tyr-184 or Phe-184, the predicted sequence of those chloroquine-sensitive isolates. No mutation at Asn-1042 and Asp-1246 was detected among these chloroquine-resistant isolates. Therefore, a few base substitutions in the pfmdr1 gene may not be sufficient to account for all chloroquine-resistant phenotypes.


Subject(s)
Antimalarials/pharmacology , Drug Resistance, Multiple/genetics , Malaria, Falciparum/drug therapy , Mefloquine/pharmacology , Plasmodium falciparum/drug effects , Amodiaquine/pharmacology , Animals , Antimalarials/therapeutic use , Chloroquine/pharmacology , Chromosome Mapping , DNA Primers/chemistry , DNA, Protozoan/chemistry , Electrophoresis, Agar Gel , Electrophoresis, Gel, Pulsed-Field , Humans , Inhibitory Concentration 50 , Mefloquine/therapeutic use , Plasmodium falciparum/genetics , Plasmodium falciparum/growth & development , Point Mutation , Polymerase Chain Reaction , Quinine/pharmacology , Scintillation Counting , Sequence Analysis, DNA , Thailand
5.
Article in English | MEDLINE | ID: mdl-9740266

ABSTRACT

The ability of Plasmodium falciparum infected erythrocytes from 162 Thai patients with uncomplicated malaria, 82 patients with severe malaria and 19 patients with cerebral malaria to form rosettes in vitro was studied. Of 263 isolates, 62 were evaluated for their adherence to different target molecules. We found that wide variation occurred in isolates from all groups in the level of rosette formation and adherence to CD36, intracellular adhesion molecule-1, thrombospondin and chondroitin sulfate A. No statistically significant correlation between the magnitude of rosette formation and disease severity was found (p > 0.05). In addition, our results from the use of purified CD36 as an adherence receptor showed no association between the degree rosetting and level of cytoadherence (p > 0.05, r = -0.04). Our data provide evidence that rosette formation and cytoadherence involve different molecular mechanisms and both phenomena can occur in all manifestations of the disease.


Subject(s)
CD36 Antigens/immunology , Erythrocytes/parasitology , Malaria, Falciparum/immunology , Rosette Formation , Adult , Cell Adhesion , Cell Adhesion Molecules , Chondroitin Sulfates/immunology , Erythrocytes/immunology , Female , Humans , Malaria, Falciparum/blood , Male , Thailand , Thrombospondins/immunology
6.
Am J Trop Med Hyg ; 55(1): 76-80, 1996 Jul.
Article in English | MEDLINE | ID: mdl-8702026

ABSTRACT

The association between cytoadherence of Plasmodium falciparum-infected erythrocytes and the severity of malaria has been evaluated. In this study, we investigate adherence to C32 melanoma cells, CD36, intracellular adhesion molecule-1 (ICAM-1), thrombospondin (TSP), E-selectin, vascular cell adhesion molecule-1 (VCAM-1), and chondroitin sulfate A (CSA) of 36 P. falciparum isolates from patients suffering from acute falciparum malaria. Adherence to purified adhesion molecules varied greatly among different parasite isolates. All isolates but one adhered to CD36, but none bound to E-selectin and VCAM-1 beyond control levels. Some P. falciparum isolates adhered to ICAM-1 and to CSA, a newly identified receptor for adherence. There was no correlation between in vitro binding to any one receptor and the patients' conditions. In addition, we investigated the characteristics of adherence to CSA and to C32 melanoma cells. Infected erythrocytes continued to adhere after trypsin digestion and soluble CSA inhibited adherence to C32 melanoma cells in a dose-dependent manner. The results imply a role for CSA in the natural infection of P. falciparum.


Subject(s)
Cell Adhesion Molecules/metabolism , Chondroitin Sulfates/metabolism , Erythrocytes/physiology , Erythrocytes/parasitology , Malaria, Falciparum/parasitology , Plasmodium falciparum , Adolescent , Adult , Animals , CD36 Antigens/metabolism , Cell Adhesion/drug effects , Cell Adhesion/physiology , Female , Humans , Male , Melanoma , Trypsin/metabolism , Tumor Cells, Cultured
SELECTION OF CITATIONS
SEARCH DETAIL
...